Presentation of Liver Failure From a Pericardial Mass.

Circ Cardiovasc Imaging

Department of Internal Medicine (Cardiology) (V.Q.N., V.W., L.Y., L.A.B.), Yale School of Medicine, New Haven, CT.

Published: June 2019

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCIMAGING.118.008672DOI Listing

Publication Analysis

Top Keywords

presentation liver
4
liver failure
4
failure pericardial
4
pericardial mass
4
presentation
1
failure
1
pericardial
1
mass
1

Similar Publications

South Asia has high prevalence rates of type 2 diabetes (T2D). Until the 1990s, the prevalence of T2D within South Asia was low but much higher in the South Asian diaspora living abroad. Today, high prevalence rates of T2D are reported among those living in South Asia.

View Article and Find Full Text PDF

Sickle cell disease (SCD) is the most common genetic disease in the world and a societal challenge. SCD is characterized by multi-organ injury related to intravascular hemolysis. To understand tissue-specific responses to intravascular hemolysis and exposure to heme, we present a transcriptomic atlas in the primary target organs of HbSS vs HbAA transgenic SCD mice.

View Article and Find Full Text PDF

Background: Hepatocellular carcinoma (HCC) encompasses rare variants like chromophobe hepatocellular carcinoma (CHCC) characterized by distinct histological features and molecular profiles.

Case Report: A 56-year-old male with chronic hepatitis C, presenting pain in the right hypochondrium. Imaging revealed a solitary liver lesion, subsequently resected and histologically diagnosed as HCC.

View Article and Find Full Text PDF

Purpose Of Review: The term metabolic dysfunction-associated steatotic liver disease (MASLD) refers to a group of progressive steatotic liver conditions that include metabolic dysfunction-associated steatohepatitis (MASH), which has varying degrees of liver fibrosis and may advance to cirrhosis, and independent hepatic steatosis. MASLD has a complex underlying mechanism, with patients exhibiting diverse causes and phases of the disease. India has a pool prevalence of MASLD of 38.

View Article and Find Full Text PDF

Recent advances in the management of pediatric cholestatic liver diseases.

J Pediatr Gastroenterol Nutr

January 2025

Department of Pediatrics, Children's Hospital of Colorado, University of Colorado, Aurora, Colorado, USA.

Pediatric cholestatic liver diseases are rare conditions that can result from multiple specific underlying etiologies. Among the most common etiologies of pediatric cholestatic liver diseases are biliary atresia, Alagille syndrome (ALGS), and inherited disorders of bile acid transport. These diseases are characterized by episodic or chronic unremitting cholestasis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!